SAM
MJN

Scopus Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Scopus Asset Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-50,000
Closed -$3.71M – 245
2013
Q3 		$3.71M Sell
50,000
-33,181
-40% -$2.49M 0.09% 141
2013
Q2 		$6.59M Buy
+83,181
New +$6.67M 0.18% 98

Other funds holding MJN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Scopus Asset Management's MJN Position: Q4 2013 in Review

Scopus Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q4 2013, closing a stake of 50,000 shares — an estimated $3.71M sold.

Scopus Asset Management first reported a position in MJN in Q2 2013 and held it in 2 quarters. The position peaked at $6.59M in Q2 2013. 483 funds tracked by Wall St. Rank hold MJN as of Q4 2013.

  • Scopus Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q4 2013 after selling out during the quarter.
  • Scopus Asset Management sold 50,000 Mead Johnson Nutrition Company shares in Q4 2013, an estimated $3.71M.
  • Scopus Asset Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 2 quarters.
  • Scopus Asset Management's Mead Johnson Nutrition Company position peaked at $6.59M in Q2 2013.
  • 483 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2013.

Based on Scopus Asset Management's 13F filing for Q4 2013, filed 13 Feb 2014.